Illumina (ILMN) weekly volatility elevated into forming partnership with IBM Watson Health to expand genome data interpretation

Illumina (NASDAQ: ILMN) January weekly call option implied volatility is at 84, January is at 68, February is at 54; compared to its 52-week range of 28 to 59 into announcing a partnership to expand access to genome data interpretation by integrating IBM (IBM) Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation

You May Also Be Interested In

• Senate Committee Investigates Ozempic and Wegovy Costs - NYT
• Teladoc (TDOC) call put ratio 1 call to 2.9 puts into quarter results
• Altria Group (MO) April weekly option implied volatility into quarter results